InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Shendelman Shoshana, Président et CEO. Officer active across 2 companies, notably Applied Therapeutics Inc.. In total, 18 reports have been published. Split: 5 buys · 5 sells. Total volume traded: €2.2m. History available since 13 September 2021. The latest transaction was filed on 5 August 2024 (Don). Regulator: SEC (Form 4). All data is openly available.
Declarations18 total
747,886 shares0Common StockSEC:0000950170-24-097309:0
61,795 shares@ US$4.3213.5% of flowCommon StockSEC:0000950170-24-071333:0
318,573 shares@ US$5.3986.5% of flowCommon StockSEC:0001096906-24-000497:0
1,100,000 shares0Common StockSEC:0001209191-23-059636:0
3,968 shares@ US$1.971.7% of flowCommon StockSEC:0001209191-23-057117:0
115,632 shares@ US$2.7070.2% of flowCommon StockSEC:0001209191-23-050892:0
15,870 shares@ US$0.913.1% of flowCommon StockSEC:0001209191-23-003290:0
50,000 shares@ US$0.6457.7% of flowCommon StockSEC:0001209191-22-053691:0
Canonical exit: 12 Jan 2023 (T+90)
73,256 shares@ US$0.55829.7% of flowCommon StockSEC:0001209191-22-053604:0
Canonical exit: 11 Jan 2023 (T+90)
38,153 shares@ US$0.52274.8% of flowCommon StockSEC:0001209191-22-053530:0
Canonical exit: 10 Jan 2023 (T+90)
120,900 shares0Common StockSEC:0001209191-22-002966:0
120,900 shares0Common StockSEC:0001209191-22-002970:0
120,900 shares0Common StockSEC:0001209191-22-002970
120,900 shares0Common StockSEC:0001209191-22-002966
120,900 shares0Common StockSEC:0001209191-21-070088
120,900 shares0Common StockSEC:0001209191-21-070088:0
701 shares@ US$14.689950.0% of flowCommon StockSEC:0001209191-21-055932:0
Canonical exit: 12 Dec 2021 (T+90)
701 shares@ US$14.68992.0% of flowCommon StockSEC:0001209191-21-055932
Canonical exit: 12 Dec 2021 (T+90)
18 of 18 declarations
About Shendelman Shoshana
Shendelman Shoshana is the President and CEO of Applied Therapeutics Inc. She leads the company and is responsible for the overall strategy and operational direction. Shoshana plays a key role in product development and market expansion, contributing to Applied Therapeutics' mission of providing innovative solutions in healthcare. Her leadership is essential for the company's success.
